• Edgewise Therapeutics Chief Financial Officer Michael Nofi converted 10,937 restricted stock units into common stock on November 10, 2026.
• Nofi held 32,813 restricted stock units following the transaction.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Edgewise Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001705477-26-000003), on November 10, 2026, and is solely responsible for the information contained therein.